KEGG enrichment analysis indicated that wolfberry’s anti-breast cancer targets are primarily enriched in cancer pathways, the estrogen signaling pathway, AGE-RAGE signaling pathway, P53 signaling pathway, and HIF-1 signaling pathway. The gene discussed is TP53; the disease is breast carcinoma.